CompletedPhase 2/3

On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation

Egypt95 participantsStarted 2024-03-01

Plain-language summary

Both Silodosin 4 mg and Dapoxetine 60 mg significantly improved IELT and sexual function scores in primary PE patients. However, Silodosin exhibited a more favorable tolerability profile with fewer side effects, making it a safer, clinically effective alternative.

Who can participate

Age range25 Years – 65 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Heterosexual male * Sexually active * Aged 25 to 65 years old. * Primary premature ejaculation (IELT \< 1 minute) * They had experienced PE for a minimum of 6 months Exclusion Criteria: * Patients with a history of diabetes or * Uncontrolled hypertension (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg) was precluded from the study. * Anatomic abnormalities of the penis or genital region, * Erectile dysfunction, * Chronic prostatitis, * Psychological disorder * Patients on anti-psychotic drugs.

What they're measuring

Intravaginal ejaculatory Latency time

Timeframe: 2 months

Trial details

NCT IDNCT07081659

SponsorBenha University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-01

View on ClinicalTrials.gov More Premature (Early) Ejaculation trials